The Impact of Vaccination Frequency on COVID-19 Public Health Outcomes: A Model-Based Analysis
Lin Yuan, Madison Stoddard, Sharanya Sarkar, Debra van Egeren, Shruthi Mangalaganesh, Ryan P. Nolan, Michael S. Rogers, Greg Hather, Laura F. White, Arijit Chakravarty

TL;DR
This paper uses models to show that frequent vaccine boosters can help maintain vaccine effectiveness against COVID-19 as immunity wanes and the virus evolves.
Contribution
The study introduces a model-based analysis to evaluate how booster frequency affects vaccine durability and public health outcomes.
Findings
Frequent booster doses (three or more times a year) can counteract declining vaccine efficacy.
Simulations suggest that maintaining high vaccination frequency preserves protection against severe disease.
The findings highlight the importance of repeated vaccination in managing the pandemic effectively.
Abstract
Background: While the rapid deployment of SARS-CoV-2 vaccines had a significant impact on the ongoing COVID-19 pandemic, rapid viral immune evasion and waning neutralizing antibody titers have degraded vaccine efficacy. Nevertheless, vaccine manufacturers and public health authorities have a number of options at their disposal to maximize the benefits of vaccination. In particular, the effect of booster schedules on vaccine performance bears further study. Methods: To better understand the effect of booster schedules on vaccine performance, we used an agent-based modeling framework and a population pharmacokinetic model to simulate the impact of boosting frequency on the durability of vaccine protection against infection and severe acute disease. Results: Our work suggests that repeated dosing at frequent intervals (three or more times a year) may offset the degradation of vaccine…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSARS-CoV-2 and COVID-19 Research · COVID-19 epidemiological studies · vaccines and immunoinformatics approaches
